高级搜索
升白欣治疗恶性肿瘤化疗所致白细胞减少症51例的临床观察[J]. 肿瘤防治研究, 1997, 24(5): 314-316.
引用本文: 升白欣治疗恶性肿瘤化疗所致白细胞减少症51例的临床观察[J]. 肿瘤防治研究, 1997, 24(5): 314-316.
The clinical effective observation of shengbaixin on treating leukopenia induced by malignant tumor chemotherapy[J]. Cancer Research on Prevention and Treatment, 1997, 24(5): 314-316.
Citation: The clinical effective observation of shengbaixin on treating leukopenia induced by malignant tumor chemotherapy[J]. Cancer Research on Prevention and Treatment, 1997, 24(5): 314-316.

升白欣治疗恶性肿瘤化疗所致白细胞减少症51例的临床观察

The clinical effective observation of shengbaixin on treating leukopenia induced by malignant tumor chemotherapy

  • 摘要: 作者运用升白欣治疗各种恶性肿瘤化疗所致白细胞减少症51例,采用肌肉注射50u,1/日连用5~7天,结果表明:升白欣可以迅速升高白细胞数,I度和Ⅱ度白细胞减少尤为显著,引例中显效39例,有效8例,总有效率92.2%,与G-csF相比疗效相当。该药升高白细胞后即使停药,亦无白细胞再度降低的现象,且毒副反应小,主要为发热和注射局部疼痛,对症处理多可缓解。

     

    Abstract: We adapted Shengbaixin to treat 51 cases of leukopenia of malignent tumor patents could which were increase caused by chemotherapy.The result indicated that Shengbaixin total white cell count rapidly,especially leukopenia of Ⅰ andⅡ.The effective the rate was 92.2%Compared with G-CSF,the efficacy has no differences .Shengbanxin's side and toxic effects were slight.

     

/

返回文章
返回